MelaFind®

Newly-approved MelaFind® uses breakthrough technology to
non-invasively and painlessly see below the skin’s surface and
objectively evaluate the three-dimensional morphological disorganization of clinically atypical pigmented skin lesions with immediate results.

The detailed information about irregular lesions, including information below the skin, is more accurate and precise than other non-surgical methods of analysis. This allows the physicians at MDLSVI to make informed decisions about biopsies and detect potential melanomas much earlier. Melanomas detected earlier have better cure rates and typically better cosmetic results as well.